“Eat less, move more” is not a long-term weight management solution. But anti-obesity medications like GLP-1 agonists can change a patient’s relationship with food so they can focus on creating healthy, sustainable habits.
Drugs like Ozempic, Wegovy, and Mounjaro are making headlines for their weight-loss prowess, but these GLP-1 RAs also reduce the risk of heart attack, stroke, and cardiovascular events in patients with Type 2 diabetes.
The parathyroid glands are important, but also tiny and tough to see during surgery. Find out how a new and advanced technology helps our surgeons in Frisco protect patients' parathyroid glands and reduce post-surgery complications.
Teplizumab, a Type 1 diabetes immunotherapy drug, has been proven to slow onset of the disease by 2 years. This landmark discovery could lead to potential reduction in long-term health risks related to diabetes. Find out how the drug works and who might benefit in this week’s MedBlog. Learn more.
Many patients panic when they hear the words “thyroid nodule.” Is it cancer? Will it grow? Do I need surgery? In this week’s blog, Iram Hussain, M.D., discusses how thyroid nodules are found, diagnosed, and treated. Learn more.
Frisco RoughRiders COO Scott Burchett found out he had thyroid cancer two days before he learned his wife was pregnant with twins. In his time of emotional turmoil, he turned to UT Southwestern's team of nationally recognized physicians to help him stare down the disease and become the dad he always hoped to be.